The Rs 650-crore issue got bids for 25.3 million shares, against the issue size of 16.39 mn, showed data put up on the National Stock Exchange website.
The qualified institutional buyers' portion was subscribed 2.4 times and the retail (small) investors segment 0.8 times. The non-institutional investors’ category was subscribed 0.4 times.
“We got a good response from institutional investors, including foreign ones, life insurance and mutual funds. Most of them belong to the long-only category,” said V Jayasankar, head of equity capital markets at Kotak Investment Banking.
This is the fourth health care IPO in the market since December. The other three -- of Alkem Laboratories, Dr Lal PathLabs and Narayana Hrudayalaya – received a good response, getting subscribed between 6.3 and 30.8 times. The retail portion in all these IPOs were subscribed by more than one times.
Kotak Mahindra Capital, Edelweiss Financial Services, IDFC Securities, Goldman Sachs, IIFL Holdings and YEs Bank are the lead managers to the HCG issue.
Experts say foreign investors have strong appetite for the health care space, seeing this as a multi-decade growth story. They estimate listed health care assets on the exchanges to be only about $3 billion (Rs 20,000 crore) and there is scope for more companies to come on board.
It is the fourth company after Precision Camshafts, TeamLease Services and Quick Heal Technologies to hit Dalal Street with an IPO in 2016.
Meanwhile, Bharat Wire Ropes' Rs 78-crore IPO, which opened on Friday, was subscribed 40 per cent. On Monday, e-commerce entity Infibeam’s Rs 450-crore IPO opens for subscription.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)